For postmenopausal women with overweight or obesity receiving tirzepatide, menopausal hormone therapy linked to increased weight loss.

(HealthDay News) — From 1999 to 2020, obesity-related cancer mortality increased significantly, according to a study presented at ENDO 2025, the annual meeting of the Endocrine Society, held from July ...

A recent study presented at ENDO 2025 reveals that artificial sweeteners like aspartame and sucralose, commonly found in diet ...

Research from ENDO 2025 reveals that GLP-1 anti-obesity medications not only aid in weight loss but also improve testosterone ...

GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity or type 2 diabetes, researchers reported in San Francisco at ENDO 2025, the ...

Adults with congenital adrenal hyperplasia treated with an oral nonsteroidal drug saw continued disease control with reduced ...

Liverpool won the 2024/25 Premier League title with limited options in midfield. Ryan Gravenberch took over No6 duties after ...

Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with ...

Pregnant Elsie Hewitt teased her "weird chaotic month" with Pete Davidson prior to announcing their baby news.

Intermittent energy restriction, time-restricted eating and continuous energy restriction can all improve blood sugar levels ...

Dietary approaches like intermittent energy restriction, time-restricted eating, and continuous energy restriction can all ...

The game-changing weight loss jabs have ushered in a new era in the war on obesity, but have also been linked to other health ...